<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="FIGURE" xml:lang="en" id="rmv2163-fig-0001" orientation="portrait" position="float">
 <label>FIGURE 1</label>
 <caption>
  <p>Anti‐viral and anti‐inflammatory effects of macrolides. Schematic showing major proposed mechanisms of azithromycin anti‐viral (green) and anti‐inflammatory or immunomodulatory (purple) activities. AZM, azithromycin; CRP, C‐reactive protein; CSF2, colony‐stimulating factor 2 (GM‐CSF); CXCL, C‐X‐C motif chemokine ligand; DC, dendritic cell; ICAM1, intracellular cell adhesion molecule 1; IFN, interferon; IL, interleukin; IRF3, Interferon Regulatory Factor 3; ISG, interferon‐stimulated gene; MDA5, melanoma differentiation‐associated protein 5; MPO, myeloperoxidase; MxA, myxoma resistance protein 1; NFκB, nuclear factor kappa B; NLRP3, nucleotide‐binding oligomerisation domain; phosTBK1, phosphorylated TANK‐binding kinase 1; PRR, pattern recognition receptor; RIG‐I, retinoic acid‐inducible gene I; RV, rhinovirus; Th17, type‐17 T‐helper; TLR, Toll‐like receptor; (s)TNF, (soluble) tissue necrosis factor</p>
 </caption>
 <graphic id="nlm-graphic-1" xlink:href="RMV-9999-e2163-g001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
